Koyfin Home > Directory > Health Care > Amicus Therapeutics > Total Equity

Amicus Therapeutics Total Equity Chart (FOLD)

Amicus Therapeutics annual/quarterly Total Equity from 2006 to 2018.
  • Amicus Therapeutics Total Equity for the quarter ending September 09, 2018 was $411m a 14.14% increase of 58m year over year
  • Amicus Therapeutics Total Equity for the last 12 months ending September 09, 2018 was $411m a 14.14% increase of 58m year over year
  • Amicus Therapeutics Annual Total Equity for 2017 was $353m a -2.07% decrease of -7m from 2016
  • Amicus Therapeutics Annual Total Equity for 2016 was $360m a 3.42% increase of 12m from 2015
  • Amicus Therapeutics Annual Total Equity for 2015 was $348m a 64.87% increase of 226m from 2014
Other Balance Sheet Metrics:
  • Amicus Therapeutics Total Assets for the quarter ending September 09, 2018 was $839m a 25.23% increase of 212m year over year
  • Amicus Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $39m a -4.44% decrease of -2m year over year
View Chart On Koyfin

Quarterly FOLD Total Equity Data

09/2018$411m
06/2018$562m
03/2018$522m
12/2017$353m
09/2017$410m
06/2017$267m
03/2017$311m
12/2016$360m
09/2016$337m
06/2016$334m

Annual FOLD Total Equity Data

2017$353m
2016$360m
2015$348m
2014$122m
2013$46m
2012$69m
2011$30m
2010$65m
2009$72m
2008$71m